Conducting dermatology clinical trials during the COVID-19 pandemic

The clinical trials industry faces a number of challenges during the evolving coronavirus disease 2019 (COVID-19) pandemic, for example, site closures, mandatory self-isolation, travel restrictions, interruptions to delivery of investigational product, or staff or participants becoming infected with...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheriff, Tabrez, Dickenson-Panas, Helen, Murrell, Dédée F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832606/
https://www.ncbi.nlm.nih.gov/pubmed/33972036
http://dx.doi.org/10.1016/j.clindermatol.2020.12.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832606/
https://www.ncbi.nlm.nih.gov/pubmed/33972036
http://dx.doi.org/10.1016/j.clindermatol.2020.12.019

Ejemplares similares